Scynexis (SCYX) Operating Margin Growth (1y) (2014 - 2026)
Scynexis (SCYX) Operating Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - | -260,756.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -260,756.00 |
| Dec 31, 2025 | 88,068.00 |
| Sep 30, 2025 | -95,283.00 |
| Jun 30, 2025 | 55,407.00 |
| Mar 31, 2025 | -265,770.00 |
| Dec 31, 2024 | -42,638.00 |
| Sep 30, 2024 | -99,021.00 |
| Jun 30, 2024 | -134,366.00 |
| Mar 31, 2024 | 25,281.00 |
| Dec 31, 2023 | 107,725.00 |
| Sep 30, 2023 | 82,677.00 |
| Jun 30, 2023 | 173,172.00 |
| Mar 31, 2023 | 187,440.00 |
| Dec 31, 2022 | 225,971.00 |
| Sep 30, 2022 | 236,744.00 |
| Mar 31, 2022 | -280,649.00 |
| Jun 30, 2019 | -767,648.00 |
| Mar 31, 2019 | -723,125.00 |
| Dec 31, 2018 | -254,531.00 |
| Sep 30, 2018 | 15,156.00 |